Estados Unidos · Revistas de economía · Axios Markets

Blackstone is becoming a biotech bank

Publicado por Axios Markets · Estados Unidos hace 20 h

Resumen detallado

Why it matters: Blackstone has become something akin to a biotech bank, helping offset drug development costs for Pfizer, Apogee, Alnylam, Boston Scientific, J&J, Merck, and…

Leer el artículo completo en Axios Markets Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.axios.com)

Blackstone is becoming a biotech bank

Resumen detallado

También te puede interesar

FAA lifts ground stop as homeland security chief blames tech upgrades for ‘overwhelming’ antiquated systems and rules out cyberattack for now

This Week, the FAA Rolled Out AI Air Traffic Management. Then It Grounded Flights Nationwide

Apple TV has a new ASL feature, offering a richer language experience beyond captions

How boards investigate a CEO: 10 parts of an internal probe

Nasdaq Drops Friday But Ends the Week Up: Stock Market Today

Nvidia stock slide wipes out more than $20B in value for Jensen Huang over 5 days

Blackstone is becoming a biotech bank

Resumen detallado

Compartir

También te puede interesar

FAA lifts ground stop as homeland security chief blames tech upgrades for ‘overwhelming’ antiquated systems and rules out cyberattack for now

This Week, the FAA Rolled Out AI Air Traffic Management. Then It Grounded Flights Nationwide

Apple TV has a new ASL feature, offering a richer language experience beyond captions

How boards investigate a CEO: 10 parts of an internal probe

Nasdaq Drops Friday But Ends the Week Up: Stock Market Today

Nvidia stock slide wipes out more than $20B in value for Jensen Huang over 5 days